Cancer scientists have combined 'liquid biopsy,' epigenetic alterations and machine learning to develop a blood test to detect and classify cancer at its earliest stages.
from All Top News -- ScienceDaily https://ift.tt/2PupjNl
from All Top News -- ScienceDaily https://ift.tt/2PupjNl
Comments
Post a Comment